Recent Early Stage I-II (A-B) Prostate Cancer News

New Survey Reveals Alarming Lack of Understanding of Prostate Cancer (November 18, 2014)

(OMNI-CancerConnect) In partnership with Men’s Health Network (MHN), Prostate Health Education Network (PHEN), ZERO – the End of Prostate Cancer and Joe Torre, four-time world champion baseball... Continue Reading

American Society of Clinical Oncology Endorses AUA/ASTRO Guidelines on the Use of Radiation Treatment After Prostatectomy (November 11, 2014)

The American Society of Clinical Oncology (ASCO) issued an endorsement of the American Urological Association (AUA)/American Society for Radiation Oncology (ASTRO) guidelines on the use of adjuvant and... Continue Reading

Radiation Therapy Benefits Selected Patients With Node-Positive Prostate Cancer (October 13, 2014)

According to a recent report published in The Journal of Clinical Oncology, men with advanced prostate cancer involving the lymph nodes may benefit from treatment with radiation in addition to hormonal... Continue Reading

Genomic Health Announces Positive Results from Latest Clinical Validation Study of Oncotype DX® as Predictor of Near- and Long-term Outcomes in Racially Diverse Group of Prostate Cancer Patients (October 1, 2014)

REDWOOD CITY, Calif., Sept. 29, 2014 – Genomic Health, Inc. (Nasdaq: GHDX) today announced strongly positive results from an additional independent clinical validation study of the Oncotype DX®... Continue Reading

Advances in Genomic Testing-What you Need to Know (September 29, 2014)

Q: What is genomic testing? A: Genomic testing looks at a group of genes and their varying levels of expression. This gene expression or activity can characterize how genes interact with one another and... Continue Reading

New Survey Reveals that Prostate Cancer Impacts Sex Lives More than Any Other Aspect of Patients’ Lives (September 11, 2014)

Washington, DC (September 8, 2014) – A recent survey conducted by ZERO – The End of Prostate Cancer and Ferring Pharmaceuticals Inc. aimed to uncover the impact of prostate cancer on patients, their... Continue Reading

Large Independent Validation Study Validates Oncotype DX Prostate Cancer Test (August 11, 2014)

Genomic Health, Inc. announced positive preliminary results from an additional independent clinical validation study conducted by the Center for Prostate Disease Research (CPDR) demonstrating that the... Continue Reading

New Research Questions Early Prostate Cancer Treatment Options (July 28, 2014)

Researchers at The University of Texas MD Anderson Cancer Center recently published their latest findings on the role a diagnosing urologist plays in deciding whether older men with low-risk prostate... Continue Reading

Data Demonstrates Benefit of Utilizing Multiple Biological Pathways to Predict Tumor Behavior in Prostate and Renal Cancers (June 9, 2014)

REDWOOD CITY, Calif., June 3, 2014 /PRNewswire/ – Genomic Health, Inc. (Nasdaq: GHDX) today announced results of two studies demonstrating the ability of its Oncotype DX® test and a new 16-gene... Continue Reading

Radical Prostatectomy Offers Long-Term Benefit Over Watchful Waiting in Early Prostate Cancer (May 22, 2014)

Researchers in Sweden recently reported in The New England Journal of Medicine that radical prostatectomy continues to show long-term benefits over watchful waiting in early prostate cancer. Follow up... Continue Reading

Next Page »